Literature DB >> 1549179

The wee1 protein kinase is required for radiation-induced mitotic delay.

R Rowley1, J Hudson, P G Young.   

Abstract

Cellular feedback or 'checkpoint' mechanisms maintain the order of completion of essential, cell-cycle related functions. In the budding yeast, for example, the RAD9 gene product is required to delay progression into mitosis in response to DNA damage. Similarly, in fission yeast, the cdc25 and cdc2 gene products influence the ability of cells to delay mitosis in response to the inhibition of DNA synthesis. Because these two checkpoint controls regulate the same event, mitosis, we observed the effect of gamma-irradiation on cell cycle progression in fission yeast, to test whether the two controls require the same cell-cycle regulatory elements. We show that gamma-radiation-induced mitotic delay requires functional wee1 protein kinase but does not seem to involve the cdc25 pathway. Mitotic delay in response to DNA damage is thus distinct from the delay induced by inhibition of DNA synthesis, which involves cdc25 but is not dependent on wee1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549179     DOI: 10.1038/356353a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  41 in total

1.  Mik1 levels accumulate in S phase and may mediate an intrinsic link between S phase and mitosis.

Authors:  P U Christensen; N J Bentley; R G Martinho; O Nielsen; A M Carr
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Coupling between gene expression and DNA synthesis early during development in Bacillus subtilis.

Authors:  K Ireton; A D Grossman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

3.  Identification of cell cycle-regulated genes in fission yeast.

Authors:  Xu Peng; R Krishna Murthy Karuturi; Lance D Miller; Kui Lin; Yonghui Jia; Pinar Kondu; Long Wang; Lim-Soon Wong; Edison T Liu; Mohan K Balasubramanian; Jianhua Liu
Journal:  Mol Biol Cell       Date:  2004-12-22       Impact factor: 4.138

Review 4.  Synthetic lethal interactions for the development of cancer therapeutics: biological and methodological advancements.

Authors:  Shinji Mizuarai; Hidehito Kotani
Journal:  Hum Genet       Date:  2010-10-26       Impact factor: 4.132

5.  The rad3+ gene of Schizosaccharomyces pombe is involved in multiple checkpoint functions and in DNA repair.

Authors:  G Jimenez; J Yucel; R Rowley; S Subramani
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

6.  A fission yeast homolog of CDC20/p55CDC/Fizzy is required for recovery from DNA damage and genetically interacts with p34cdc2.

Authors:  T Matsumoto
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

7.  Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors.

Authors:  Suzanne Leijen; Robin M J M van Geel; Anna C Pavlick; Raoul Tibes; Lee Rosen; Albiruni R Abdul Razak; Raymond Lam; Tim Demuth; Shelonitda Rose; Mark A Lee; Tomoko Freshwater; Stuart Shumway; Li Wen Liang; Amit M Oza; Jan H M Schellens; Geoffrey I Shapiro
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

8.  Late induction of human DNA ligase I after UV-C irradiation.

Authors:  A Montecucco; E Savini; G Biamonti; M Stefanini; F Focher; G Ciarrocchi
Journal:  Nucleic Acids Res       Date:  1995-03-25       Impact factor: 16.971

9.  Functional analysis of the Drosophila CDC2 Dm gene in fission yeast.

Authors:  E R Bejarano; M J Muñoz; J Jimenez
Journal:  Mol Gen Genet       Date:  1995-09-20

10.  Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor.

Authors:  Shinji Mizuarai; Kazunori Yamanaka; Hiraku Itadani; Tsuyoshi Arai; Toshihide Nishibata; Hiroshi Hirai; Hidehito Kotani
Journal:  Mol Cancer       Date:  2009-06-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.